|
|
|
Volumn 12, Issue 7, 2009, Pages 404-408
|
|
American society of clinical oncology - 45th annual meeting
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AFLIBERCEPT;
ALANINE AMINOTRANSFERASE;
AMG 655;
ANTINEOPLASTIC AGENT;
ASPARTATE AMINOTRANSFERASE;
BAY 73 4506;
BEVACIZUMAB;
BMS 907351;
CARBOPLATIN;
CETUXIMAB;
CISPLATIN;
CLORETAZINE;
CNTO 328;
CONATUMUMAB;
CYTARABINE;
DOCETAXEL;
DOXORUBICIN;
ERLOTINIB;
GEMCITABINE;
HEPARIN DERIVATIVE;
IPH 2101;
LAROMUSTINE;
LY 2334737;
ONRIGIN;
OXALIPLATIN;
PACLITAXEL;
PANITUMUMAB;
PANOBINOSTAT;
PAZOPANIB;
PEMETREXED;
PREDNISOLONE;
SILTUXIMAB;
SULFATED NON ANTICOAGULATION HEPARIN;
TINZAPARIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VANDETANIB;
XL 184;
ABDOMINAL PAIN;
ACUTE GRANULOCYTIC LEUKEMIA;
ACUTE KIDNEY FAILURE;
ADVANCED CANCER;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ALOPECIA;
ANOREXIA;
ANTINEOPLASTIC ACTIVITY;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
BLOOD TOXICITY;
BRADYCARDIA;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PATIENT;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONFERENCE PAPER;
CONFUSION;
CONTINUOUS INFUSION;
COUGHING;
CREATININE BLOOD LEVEL;
DEEP VEIN THROMBOSIS;
DEHYDRATION;
DIARRHEA;
DIGESTIVE SYSTEM PERFORATION;
DISEASE FREE SURVIVAL;
DIZZINESS;
DRUG DOSE ESCALATION;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DYSPNEA;
FATIGUE;
FEVER;
FLU LIKE SYNDROME;
GASTROINTESTINAL HEMORRHAGE;
GLIOBLASTOMA;
HEADACHE;
HUMAN;
HYPERKALEMIA;
HYPERTENSION;
HYPERURICEMIA;
LEUKOPENIA;
LIVER CELL CARCINOMA;
LUNG CANCER;
LUNG EMBOLISM;
LUNG INSUFFICIENCY;
LUNG NON SMALL CELL CANCER;
LYMPHOCYTOPENIA;
MALAISE;
MEDICAL SOCIETY;
MESOTHELIOMA;
MONOTHERAPY;
MULTIPLE CYCLE TREATMENT;
MULTIPLE MYELOMA;
MYELODYSPLASTIC SYNDROME;
NAUSEA;
NEUTROPENIA;
NONHUMAN;
OVERALL SURVIVAL;
PAIN;
PANCREAS CANCER;
PROGNOSIS;
PROGRESSION FREE SURVIVAL;
PROSTATE CANCER;
PROTEINURIA;
RASH;
RECOMMENDED DRUG DOSE;
SEPSIS;
SIDE EFFECT;
SKIN TOXICITY;
SOLID TUMOR;
SQUAMOUS CELL CARCINOMA;
SURVIVAL RATE;
SYNCOPE;
TACHYCARDIA;
THROMBOCYTOPENIA;
TREATMENT DURATION;
TREATMENT RESPONSE;
TRIACYLGLYCEROL LIPASE BLOOD LEVEL;
VOICE CHANGE;
VOMITING;
WOUND COMPLICATION;
XEROSTOMIA;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
DRUGS, INVESTIGATIONAL;
HUMANS;
MEDICAL ONCOLOGY;
MOLECULAR STRUCTURE;
NEOPLASMS;
|
|
EID: 68149087640
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
